ADMINISTRATIVE CORE FOR CENTER MANAGEMENT AND OPERATIONS Key Personnel: Jeffrey D. Laskin, Ph.D., Director and P.I. Donald Gerecke, Ph.D., Deputy Director Kristin Borberly, Center Administrator Linda Everett, Administrative Secretary Core Summary/Abstract The Administrative Core is responsible for the day-to-day operations of the Center, promoting continuity and scientific interactions between Center members at Rutgers, Lehigh and New York Medical College and corporate partners (MRIGlobal, Janssen, Azevam, Bristol Myers Squibb) that facilitate drug development; the Core will oversee the management and activities of the Research and Development Projects, the Scientific Support Cores, and the Research Education Core, and be responsible for establishing, refining and implementing the overall goals of the Center. The Administrative Core will oversee research project milestones, ensuring that they are defined with quantitative success criteria that facilitate go/no go decisions, and that they advance the goals of the Center. The Core will ensure that project specific aims facilitate synergism between the research cores, and that the research is integrated into the overall goals, objectives and milestones of the Center. The Administrative Core will oversee the effective use of Scientific Support Core resources to further research and development activities. It will also provide an effective planning and evaluation process that assesses productivity of research projects and allocation of resources. Additional activities of the Administrative Core include providing statistical support, coordinating intellectual property and patenting, establishing goals and metrics, communicating with institutional officials, and oversight of progression of candidate therapeutics. By effective management of the Center, the Administrative Core will ensure that the overall Rutgers CounterACT Center will continue to be highly integrated and be greater than the sum of its parts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54AR055073-11
Application #
9151414
Study Section
Special Emphasis Panel (ZRG1-MDCN-B (54)R)
Project Start
2006-09-15
Project End
2021-08-31
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
11
Fiscal Year
2016
Total Cost
$153,794
Indirect Cost
$57,068
Name
Rbhs-Robert Wood Johnson Medical School
Department
Type
DUNS #
078795875
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Moretti, Alysha; Li, Qi; Chmielowski, Rebecca et al. (2018) Nanotherapeutics Containing Lithocholic Acid-Based Amphiphilic Scorpion-Like Macromolecules Reduce In Vitro Inflammation in Macrophages: Implications for Atherosclerosis. Nanomaterials (Basel) 8:
Szilagyi, John T; Fussell, Karma C; Wang, Yun et al. (2018) Quinone and nitrofurantoin redox cycling by recombinant cytochrome b5 reductase. Toxicol Appl Pharmacol 359:102-107
Joseph, Laurie B; Composto, Gabriella M; Perez, Roberto M et al. (2018) Sulfur mustard induced mast cell degranulation in mouse skin is inhibited by a novel anti-inflammatory and anticholinergic bifunctional prodrug. Toxicol Lett 293:77-81
Chang, Yoke-Chen; Gordon, Marion K; Gerecke, Donald R (2018) Expression of Laminin 332 in Vesicant Skin Injury and Wound Repair. Clin Dermatol (Wilmington) 2:
Yang, Shaojun; Jan, Yi-Hua; Mishin, Vladimir et al. (2017) Diacetyl/l-Xylulose Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells. Chem Res Toxicol 30:1406-1418
Venosa, Alessandro; Gow, James G; Hall, LeRoy et al. (2017) Regulation of Nitrogen Mustard-Induced Lung Macrophage Activation by Valproic Acid, a Histone Deacetylase Inhibitor. Toxicol Sci 157:222-234
Francis, Mary; Sun, Richard; Cervelli, Jessica A et al. (2017) Editor's Highlight: Role of Spleen-Derived Macrophages in Ozone-Induced Lung Inflammation and Injury. Toxicol Sci 155:182-195
Chmielowski, Rebecca A; Abdelhamid, Dalia S; Faig, Jonathan J et al. (2017) Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation. Acta Biomater 57:85-94
Francis, Mary; Groves, Angela M; Sun, Richard et al. (2017) Editor's Highlight: CCR2 Regulates Inflammatory Cell Accumulation in the Lung and Tissue Injury following Ozone Exposure. Toxicol Sci 155:474-484
Malaviya, Rama; Laskin, Jeffrey D; Laskin, Debra L (2017) Anti-TNF? therapy in inflammatory lung diseases. Pharmacol Ther 180:90-98

Showing the most recent 10 out of 145 publications